Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Since 2002 Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders.

Incyte’s unique expertise in medicinal chemistry and biology have enabled us to create a diversified pipeline of clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing portfolio of medicines across Oncology and Inflammation & Autoimmunity.

Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For more information, visit Incyte.com and follow @Incyte.

Living With Myelofibrosis

Myeloproliferative Neoplasm Symptom Assessment Form

Polycythemia Vera Tracker Tool

Myelofibrosis Symptoms Tracker

Communicate Your Symptoms to Your Healthcare Team, Polycythemia Vera (PV)

Living with Polycythemia Vera (PV)

Understanding Relapsed or Refractory Diffuse Large B-cell Lymphoma

Understanding Relapsed or Refractory Diffuse Large B-cell Lymphoma (Spanish)

Password: LLS22!

Please make sure the password is typed in ALL CAPS and includes the exclamation point.  Enter the email address that you used to register for the conference.